跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials - TGA Drug Approval Details
Approvals
/
TGA
/
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
Approved
STANDARD
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
Chiesi Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2823ecbb8f091472
Company
Chiesi Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2823ecbb8f091472
Product Name
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
Artg Id
203313
Artg Name
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
Sponsor
Chiesi Australia Pty Ltd
Company Detail Path
/organization/chiesi-australia-pty-ltd
Artg Date
2013-06-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01627-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01626-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2823ecbb8f091472
Type
Standard
Back to TGA Approvals